enGene Therapeutics Inc. (ENGN) › Net IncomeenGene Therapeutics Inc. (ENGN) — Net IncomeAnnual figures by period end, from SEC filings.2022-10-31: -$24.46M2023-10-31: -$99.92M2024-10-31: -$55.14M2025-10-31: -$117.30M-$117.30M2022-10-31Net Income (USD)2025-10-31Period endedNet IncomeChange YoYSource filing2025-10-31-$117.30M—2025-12-22From 2024-11-012024-10-31-$55.14M—2025-12-22From 2023-11-012023-10-31-$99.92M—2024-12-19From 2022-11-012022-10-31-$24.46M—2024-01-29From 2021-11-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)